Roche Backs Out Of Daclizumab Transplantation Deal With PDL

PDL is moving forward with Phase II development of the biologic in multiple sclerosis with partner Biogen Idec.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet